Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

Why is Bitcoin hitting new all-time highs? How are Trump's tariffs impacting US markets? Why is Ford recalling over 850,000 cars? What caused Amazon's stock price target hike? How is AI influencing cloud growth forecasts? Why is Walmart recalling 850,000 water bottles? What effect do tariffs have on copper prices?

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

benzinga.com/markets/equities/25/07/46364024/trump-threatens-200-pharma-tariffs-but-analyst-says-this-stock-is-immune-and-expected-to-benefit

While President Donald Trump's proposed 200% tariffs on pharmaceutical imports could potentially squeeze the profit margins, this stock is poised to “benefit” from the levies.
What Happened: Trump announced on Tuesday that the pharma tariffs, part of a Section 232 investigation launched…

This story appeared on benzinga.com, 2025-07-11 11:57:43.